CSS 11 – Basic research on HIV/AIDS, tuberculosis and STIs

Last updated on 12 June 2025

Perimeter

  • Basic research aimed at advancing knowledge about human immunodeficiency viruses (HIV) and simian immunodeficiency viruses (SIV), AIDS, tuberculosis and sexually transmitted infections (STIs);
  • Research in biology, biochemistry, biophysics, bioinformatics, genetics and any other discipline that contributes to understanding the stages of the viral cycle, the adaptation of the pathogen to the host and vice versa, at the
  • structural, molecular and cellular levels;
  • Research on transmission mechanisms at the cellular, mucosal and individual levels, on the induction of innate and adaptive responses, inflammation, establishment, characterisation and control of viral reservoirs;
  • Basic research in immunology, virology, genetics, systems biology and other disciplines, particularly research on the mechanisms determining pathogenesis, persistence and host responses, with priority given to those relevant to understanding infection, its control and prevention;
  • Basic research on pathogen-host interactions and their evolution in animals (in vivo) and humans (ex vivo), particularly research using resources from ANRS | Emerging Infectious Diseases cohorts, biobanks and networks.

Chair


Lydie TRAUTMANN
Global Infectious Diseases, Henry M Jackson Foundation (HJF) Bethesda, MD, USA

Vice-chair


Andrea CIMARELLI
Ecole Normale Supérieure, CIRI, Lyon, France

Members of foreign institutions

Julie BOUCAU (Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA)
Angela CIUFFI (CHUV and University of Lausanne, Switzerland)
Jimmy DIKEAKOS (Department of Microbiology and Immunology, University of Western Ontario, London, Canada)
Geneviève FOUDA (Pediatrics Weill Cornell Medicine, New York, USA)
Christine GOFFINET (Liverpool School of Tropical Medicine, Liverpool, United Kingdom)
Delia GOLETTI (Translational Research Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani” IRCCS, Rome, Italia)

Nathalie JACOBS (Faculty of Medical Sciences, Department of Biomedical and Preclinical Sciences – GIGA I3 – Cellular and Molecular Immunology, Liège, Belgium)
Morgane ROLLAND (U.S. military HIV research program, WRAIR, Bethesda, MD, USA)
Jean-Pierre ROUTY (McGill University, Montreal, Canada)
Susana VALENTE (The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology Jupiter FL, USA)
François VILLINGER (New Iberia Research Center, University of Louisiana at Lafayette, LA, USA)

Members of French institutions

Alain BAULARD (Institut Pasteur Lille, Lille, France)
Edouard BERTRAND (Montpellier Institute of Molecular Genetics, IGMM, RNA Biogenesis, Montpellier, France)
Roland BROSCH (CNRS – UMR6047 – Integrative and Molecular Microbiology, Institut Pasteur, Paris, France)
Charlotte CHARPENTIER (University of Paris IAME, UMR 1137, AP-HP, Bichat-Claude Bernard Hospital, Paris, France)
Nathalie DEJUCQ-RAINSFORD (University of Rennes, IRSET, Rennes, France)
Francesca DI NUNZIO (CNRS-URA1961, Institut Pasteur, Department of Virology, Paris, France)
Jean-Louis HERRMANN (UVSQ, Raymond-Poincaré Hospital, Garches, France)
Bernard LAGANE (UMR 1043, CHU Purpan, Toulouse, France)

Laleh MAJLESSI (Pasteur-TheraVectys Joint Lab, Institut Pasteur, Paris, France)
Florence MARGOTTIN-GOGUET (Inserm U1016 – CNRS UMR8104, Inserm, Paris, France)
Jérôme NIGOU (Institute of Pharmacology and Structural Biology, Paul Sabatier University, Toulouse, France)
Olivia PEUCHANT (Bordeaux University Hospital, bacteriology laboratory, Pellegrin Hospital, Bordeaux, France)
Olivier ROHR (IUT Louis Pasteur, Department of Parasitology and Tropical Pathology, Strasbourg, France)
Agathe SUBTIL (Cell biology of microbial infection, Institut Pasteur, Paris, France)
Eve TODESCO (Paris Sorbonne University, Virology Department, Pitié-Salpêtrière Hospital, Paris, France)